Herbas VPB

Print
EN | LT
LT - Sulfonamido dariniai kaip Bcl-2-selektyviąją apoptozę sukeliantys agentai, skirti vėžio ir imuninių ligų gydymui
EN - SULFONAMIDE DERIVATIVES AS BCL-2-SELECTIVE APOPTOSIS-INDUCING AGENTS FOR THE TREATMENT OF CANCER AND IMMUNE DISEASES

Legal status

Patent lapsed (non-payment of fees)

Bibliographic data
Indications of the International Patent Classification (IPC)
(51) INT.CL. C07D 405/12 (2006.01)
A61K 31/404 (2006.01)
A61P 35/00 (2006.01)
C07D 309/14 (2006.01)
C07D 215/20 (2006.01)
C07D 217/16 (2006.01)
C07D 231/56 (2006.01)
C07D 401/12 (2006.01)
C07D 235/26 (2006.01)
C07D 417/12 (2006.01)
C07D 249/04 (2006.01)
C07D 209/32 (2006.01)
C07D 295/125 (2006.01)
C07D 295/14 (2006.01)
C07D 211/96 (2006.01)
C07D 213/64 (2006.01)
European patent
(11) Number of the document 2376480
(13) Kind of document T
(96) European patent application number 09795606.4
Date of filing the European patent application 2009-12-04
(97) Date of publication of the European application 2011-10-19
(45) Date of publication and mention of the grant of the patent 2016-06-01
(46) Date of publication of the claims translation 2016-09-12
PCT application
(86) Number PCT/US2009/066790
Date 2009-12-04
PCT application publication
(87) Number WO 2010/065865
Date 2010-06-10
Priority applications
(30) Number Date Country code
120275 P 2008-12-05 US
181180 P 2009-05-26 US
Inventors
(72)
BRUNCKO, Milan, US
DING, Hong, US
DOHERTY, George, A., US
ELMORE, Steven, W., US
HASVOLD, Lisa, US
HEXAMER, Laura, US
KUNZER, Aaron, R., US
MANTEI, Robert, A., US
MCCLELLAN, William, J., US
PARK, Chang, H., US
PARK, Cheol-min, US
PETROS, Andrew, M., US
SONG, Xiaohong, US
SOUERS, Andrew, J., US
SULLIVAN, Gerard, M., US
TAO, Zhi-fu, US
WANG, Gary, T., US
WANG, Le, US
WANG, Xilu, US
WENDT, Michael, D., US
Grantee
(73) AbbVie Inc., 1 North Waukegan Road, North Chicago, IL 60064, US
Attorney or representative
(74) Reda ŽABOLIENĖ, METIDA, Verslo centras "VERTAS", Gynėjų g. 16, LT-01109 Vilnius, LT
Title
(54) Sulfonamido dariniai kaip Bcl-2-selektyviąją apoptozę sukeliantys agentai, skirti vėžio ir imuninių ligų gydymui
  SULFONAMIDE DERIVATIVES AS BCL-2-SELECTIVE APOPTOSIS-INDUCING AGENTS FOR THE TREATMENT OF CANCER AND IMMUNE DISEASES
Last renewal fee
Payment date Validity (years) Amount
2020-11-19 12 289.00 EUR
Legal status
Patent lapsed (non-payment of fees)
Invalidation date 2021-12-04